Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoxaline derivatives and their use for treating benign and malignant tumour disorders

Quinoxaline derivatives and their use for treating benign and malignant tumour disorders

US Patent 8394801 · Granted Mar 12, 2013

Estimated economic value: $1,341,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting Nrip1 to alleviate metabolic disease2024
Complexes for gene deletion and editing2022
Method and system for protected communication between a mobile unit coupled to a2020
Method for preventing deactivation of online services in a vehicle2020
Method and information system for informing a driver of a vehicle regarding the 2019
Glucan-encapsulated siRNA for treating type 2 diabetes mellitus2018
Method and information system for informing a driver of a vehicle regarding the 2018
Compositions and methods for inducing myoblast differentiation and myotube forma2016
Compositions and methods for decreasing leukocyte extravasation and vessel fluid2016
Pyridopyrazine derivatives and their use2015
Pyridopyrazine derivatives and their use2015
Pyridopyrazine derivatives and their use2015